WebSep 2, 2024 · DermTech markets and develops products that facilitate the early detection of skin cancers, and is developing products that assess inflammatory diseases and … WebApr 12, 2024 · DermTech Inc does not have a meaningful P/E due to negative earnings over the last 12 trailing months. DermTech Inc’s trailing 12-month revenue is $14.5 million with a -803.7% profit margin. Year-over-year quarterly sales growth most recently was -6.3%. ... The American Association of Individual Investors is an independent, nonprofit ...
DermTech Reports Third-Quarter 2024 Financial Results
WebApr 11, 2024 · LA JOLLA, Calif., April 11, 2024--DermTech, Inc. (NASDAQ: DMTK) ("DermTech" or the "Company"), a leader in precision dermatology enabled by a non-invasive skin genomics platform, today announced an agreement with a Blues plan in North Carolina. The contract, which is in addition to a favorable coverage policy that became … WebMar 9, 2024 · DermTech also has multiple contracts with preferred provider networks, including CareFirst Blue Cross/Blue Shield. According to Dobak, DermTech's PLA costs $760 per run, which he argued yields up to $240 in cost savings per test compared to the cost of standard detection methods, and reduces potential downstream complications if … ian pickles bdo
DermTech Secures Billing Codes for its Proprietary Melanoma Test
WebApr 13, 2024 · This random double-opt-in survey of 1,000 millennials and 1,000 Gen X respondents was commissioned by DermTech between October 31 and ... whose team members are members of the Market Research Society and have corporate membership to the American Association for Public Opinion Research (AAPOR) and the European … WebNov 3, 2024 · LA JOLLA, Calif.--(BUSINESS WIRE)--Nov. 3, 2024-- DermTech, Inc. (NASDAQ: DMTK) (“DermTech” or the “Company”), a leader in precision dermatology enabled by a non-invasive skin genomics platform, today reported its third-quarter 2024 financial results. “We achieved meaningful year-over-year billable sample volume … WebSep 2, 2024 · LA JOLLA, Calif.-- ( BUSINESS WIRE )-- DermTech, Inc. (NASDAQ: DMTK) (“DermTech”), a leader in precision dermatology enabled by a non-invasive skin … ian pickford